Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction

Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction

Abstract Systemic sclerosis (SSc) is a rare connective tissue disease associated with rapid evolving interstitial lung disease (ILD), driving its mortality. Specific biomarkers associated with the progression of this lung disease are highly needed. We aimed to identify specific biomarkers of SSc-ILD...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Julien Guiot, Makon-Sébastien Njock, Béatrice André, Fanny Gester, Monique Henket, Dominique de Seny, Catherine Moermans, Michel G. Malaise, Renaud Louis
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/332d152eea1a43e2b6806c3da08770b0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares